新型コロナウイルス感染症 抗原キットの世界市場インサイト・予測(~2028年)

◆英語タイトル:Global COVID-19 Antigen Kit Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22MA00001)◆商品コード:QY22MA00001
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年3月
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

新型コロナウイルス感染症のパンデミックにより、世界の新型コロナウイルス感染症 抗原キットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に新型コロナウイルス感染症 抗原キットの世界市場のxxx%を占める「高速検出キット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「家庭用」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の新型コロナウイルス感染症 抗原キットの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの新型コロナウイルス感染症 抗原キット市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの新型コロナウイルス感染症 抗原キット市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

新型コロナウイルス感染症 抗原キットのグローバル主要メーカーには、Assay Genie、Arista Biotech、Becton、Ellume、iHealth Lab、Quest Diagnostics、Abbott、Quidel、BioFire Diagnostics、BGI Genomics、BioMedomics、Cepheid、Chembio Diagnostics、などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

新型コロナウイルス感染症 抗原キット市場は、種類と用途によって区分されます。世界の新型コロナウイルス感染症 抗原キット市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
高速検出キット、PCRキット

【用途別セグメント】
家庭用、クリニック、病院、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 新型コロナウイルス感染症 抗原キット製品概要
- 種類別市場(高速検出キット、PCRキット)
- 用途別市場(家庭用、クリニック、病院、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の新型コロナウイルス感染症 抗原キット販売量予測2017-2028
- 世界の新型コロナウイルス感染症 抗原キット売上予測2017-2028
- 新型コロナウイルス感染症 抗原キットの地域別販売量
- 新型コロナウイルス感染症 抗原キットの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別新型コロナウイルス感染症 抗原キット販売量
- 主要メーカー別新型コロナウイルス感染症 抗原キット売上
- 主要メーカー別新型コロナウイルス感染症 抗原キット価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(高速検出キット、PCRキット)
- 新型コロナウイルス感染症 抗原キットの種類別販売量
- 新型コロナウイルス感染症 抗原キットの種類別売上
- 新型コロナウイルス感染症 抗原キットの種類別価格
・用途別市場規模(家庭用、クリニック、病院、その他)
- 新型コロナウイルス感染症 抗原キットの用途別販売量
- 新型コロナウイルス感染症 抗原キットの用途別売上
- 新型コロナウイルス感染症 抗原キットの用途別価格
・北米市場
- 北米の新型コロナウイルス感染症 抗原キット市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症 抗原キット市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの新型コロナウイルス感染症 抗原キット市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症 抗原キット市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の新型コロナウイルス感染症 抗原キット市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症 抗原キット市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の新型コロナウイルス感染症 抗原キット市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症 抗原キット市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの新型コロナウイルス感染症 抗原キット市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症 抗原キット市場規模(トルコ、サウジアラビア)
・企業情報
Assay Genie、Arista Biotech、Becton、Ellume、iHealth Lab、Quest Diagnostics、Abbott、Quidel、BioFire Diagnostics、BGI Genomics、BioMedomics、Cepheid、Chembio Diagnostics、
・産業チェーン及び販売チャネル分析
- 新型コロナウイルス感染症 抗原キットの産業チェーン分析
- 新型コロナウイルス感染症 抗原キットの原材料
- 新型コロナウイルス感染症 抗原キットの生産プロセス
- 新型コロナウイルス感染症 抗原キットの販売及びマーケティング
- 新型コロナウイルス感染症 抗原キットの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 新型コロナウイルス感染症 抗原キットの産業動向
- 新型コロナウイルス感染症 抗原キットのマーケットドライバー
- 新型コロナウイルス感染症 抗原キットの課題
- 新型コロナウイルス感染症 抗原キットの阻害要因
・主な調査結果

COVID-19 Antigen Kit are rapid antigen tests used to detect COVID-19 infection.

Market Analysis and Insights: Global COVID-19 Antigen Kit Market

Due to the COVID-19 pandemic, the global COVID-19 Antigen Kit market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Rapid Detection Kit accounting for % of the COVID-19 Antigen Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Domestic Use segment is altered to an % CAGR throughout this forecast period.

China COVID-19 Antigen Kit market size is valued at US$ million in 2021, while the US and Europe COVID-19 Antigen Kit are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe COVID-19 Antigen Kit landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of COVID-19 Antigen Kit include Assay Genie, Arista Biotech, Becton, Ellume, iHealth Lab, Quest Diagnostics, Abbott, Quidel and BioFire Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global COVID-19 Antigen Kit Scope and Segment

COVID-19 Antigen Kit market is segmented by Type and by Application. Players, stakeholders, and other participants in the global COVID-19 Antigen Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Rapid Detection Kit

PCR Kit

Segment by Application

Domestic Use

Clinic

Hospital

Others

By Company

Assay Genie

Arista Biotech

Becton

Ellume

iHealth Lab

Quest Diagnostics

Abbott

Quidel

BioFire Diagnostics

BGI Genomics

BioMedomics

Cepheid

Chembio Diagnostics

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

❖ レポートの目次 ❖

1 Study Coverage

1.1 COVID-19 Antigen Kit Product Introduction

1.2 Market by Type

1.2.1 Global COVID-19 Antigen Kit Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Rapid Detection Kit

1.2.3 PCR Kit

1.3 Market by Application

1.3.1 Global COVID-19 Antigen Kit Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Domestic Use

1.3.3 Clinic

1.3.4 Hospital

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global COVID-19 Antigen Kit Sales Estimates and Forecasts 2017-2028

2.2 Global COVID-19 Antigen Kit Revenue Estimates and Forecasts 2017-2028

2.3 Global COVID-19 Antigen Kit Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global COVID-19 Antigen Kit Sales by Region

2.4.1 Global COVID-19 Antigen Kit Sales by Region (2017-2022)

2.4.2 Global Sales COVID-19 Antigen Kit by Region (2023-2028)

2.5 Global COVID-19 Antigen Kit Revenue by Region

2.5.1 Global COVID-19 Antigen Kit Revenue by Region (2017-2022)

2.5.2 Global COVID-19 Antigen Kit Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global COVID-19 Antigen Kit Sales by Manufacturers

3.1.1 Global Top COVID-19 Antigen Kit Manufacturers by Sales (2017-2022)

3.1.2 Global COVID-19 Antigen Kit Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of COVID-19 Antigen Kit in 2021

3.2 Global COVID-19 Antigen Kit Revenue by Manufacturers

3.2.1 Global COVID-19 Antigen Kit Revenue by Manufacturers (2017-2022)

3.2.2 Global COVID-19 Antigen Kit Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by COVID-19 Antigen Kit Revenue in 2021

3.3 Global COVID-19 Antigen Kit Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global COVID-19 Antigen Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global COVID-19 Antigen Kit Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global COVID-19 Antigen Kit Sales by Type

4.1.1 Global COVID-19 Antigen Kit Historical Sales by Type (2017-2022)

4.1.2 Global COVID-19 Antigen Kit Forecasted Sales by Type (2023-2028)

4.1.3 Global COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

4.2 Global COVID-19 Antigen Kit Revenue by Type

4.2.1 Global COVID-19 Antigen Kit Historical Revenue by Type (2017-2022)

4.2.2 Global COVID-19 Antigen Kit Forecasted Revenue by Type (2023-2028)

4.2.3 Global COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

4.3 Global COVID-19 Antigen Kit Price by Type

4.3.1 Global COVID-19 Antigen Kit Price by Type (2017-2022)

4.3.2 Global COVID-19 Antigen Kit Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global COVID-19 Antigen Kit Sales by Application

5.1.1 Global COVID-19 Antigen Kit Historical Sales by Application (2017-2022)

5.1.2 Global COVID-19 Antigen Kit Forecasted Sales by Application (2023-2028)

5.1.3 Global COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

5.2 Global COVID-19 Antigen Kit Revenue by Application

5.2.1 Global COVID-19 Antigen Kit Historical Revenue by Application (2017-2022)

5.2.2 Global COVID-19 Antigen Kit Forecasted Revenue by Application (2023-2028)

5.2.3 Global COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

5.3 Global COVID-19 Antigen Kit Price by Application

5.3.1 Global COVID-19 Antigen Kit Price by Application (2017-2022)

5.3.2 Global COVID-19 Antigen Kit Price Forecast by Application (2023-2028)

6 North America

6.1 North America COVID-19 Antigen Kit Market Size by Type

6.1.1 North America COVID-19 Antigen Kit Sales by Type (2017-2028)

6.1.2 North America COVID-19 Antigen Kit Revenue by Type (2017-2028)

6.2 North America COVID-19 Antigen Kit Market Size by Application

6.2.1 North America COVID-19 Antigen Kit Sales by Application (2017-2028)

6.2.2 North America COVID-19 Antigen Kit Revenue by Application (2017-2028)

6.3 North America COVID-19 Antigen Kit Market Size by Country

6.3.1 North America COVID-19 Antigen Kit Sales by Country (2017-2028)

6.3.2 North America COVID-19 Antigen Kit Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe COVID-19 Antigen Kit Market Size by Type

7.1.1 Europe COVID-19 Antigen Kit Sales by Type (2017-2028)

7.1.2 Europe COVID-19 Antigen Kit Revenue by Type (2017-2028)

7.2 Europe COVID-19 Antigen Kit Market Size by Application

7.2.1 Europe COVID-19 Antigen Kit Sales by Application (2017-2028)

7.2.2 Europe COVID-19 Antigen Kit Revenue by Application (2017-2028)

7.3 Europe COVID-19 Antigen Kit Market Size by Country

7.3.1 Europe COVID-19 Antigen Kit Sales by Country (2017-2028)

7.3.2 Europe COVID-19 Antigen Kit Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific COVID-19 Antigen Kit Market Size by Type

8.1.1 Asia Pacific COVID-19 Antigen Kit Sales by Type (2017-2028)

8.1.2 Asia Pacific COVID-19 Antigen Kit Revenue by Type (2017-2028)

8.2 Asia Pacific COVID-19 Antigen Kit Market Size by Application

8.2.1 Asia Pacific COVID-19 Antigen Kit Sales by Application (2017-2028)

8.2.2 Asia Pacific COVID-19 Antigen Kit Revenue by Application (2017-2028)

8.3 Asia Pacific COVID-19 Antigen Kit Market Size by Region

8.3.1 Asia Pacific COVID-19 Antigen Kit Sales by Region (2017-2028)

8.3.2 Asia Pacific COVID-19 Antigen Kit Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America COVID-19 Antigen Kit Market Size by Type

9.1.1 Latin America COVID-19 Antigen Kit Sales by Type (2017-2028)

9.1.2 Latin America COVID-19 Antigen Kit Revenue by Type (2017-2028)

9.2 Latin America COVID-19 Antigen Kit Market Size by Application

9.2.1 Latin America COVID-19 Antigen Kit Sales by Application (2017-2028)

9.2.2 Latin America COVID-19 Antigen Kit Revenue by Application (2017-2028)

9.3 Latin America COVID-19 Antigen Kit Market Size by Country

9.3.1 Latin America COVID-19 Antigen Kit Sales by Country (2017-2028)

9.3.2 Latin America COVID-19 Antigen Kit Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

9.3.6 Colombia

10 Middle East and Africa

10.1 Middle East and Africa COVID-19 Antigen Kit Market Size by Type

10.1.1 Middle East and Africa COVID-19 Antigen Kit Sales by Type (2017-2028)

10.1.2 Middle East and Africa COVID-19 Antigen Kit Revenue by Type (2017-2028)

10.2 Middle East and Africa COVID-19 Antigen Kit Market Size by Application

10.2.1 Middle East and Africa COVID-19 Antigen Kit Sales by Application (2017-2028)

10.2.2 Middle East and Africa COVID-19 Antigen Kit Revenue by Application (2017-2028)

10.3 Middle East and Africa COVID-19 Antigen Kit Market Size by Country

10.3.1 Middle East and Africa COVID-19 Antigen Kit Sales by Country (2017-2028)

10.3.2 Middle East and Africa COVID-19 Antigen Kit Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Assay Genie

11.1.1 Assay Genie Corporation Information

11.1.2 Assay Genie Overview

11.1.3 Assay Genie COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Assay Genie COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Assay Genie Recent Developments

11.2 Arista Biotech

11.2.1 Arista Biotech Corporation Information

11.2.2 Arista Biotech Overview

11.2.3 Arista Biotech COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Arista Biotech COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Arista Biotech Recent Developments

11.3 Becton

11.3.1 Becton Corporation Information

11.3.2 Becton Overview

11.3.3 Becton COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Becton COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Becton Recent Developments

11.4 Ellume

11.4.1 Ellume Corporation Information

11.4.2 Ellume Overview

11.4.3 Ellume COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Ellume COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Ellume Recent Developments

11.5 iHealth Lab

11.5.1 iHealth Lab Corporation Information

11.5.2 iHealth Lab Overview

11.5.3 iHealth Lab COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 iHealth Lab COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 iHealth Lab Recent Developments

11.6 Quest Diagnostics

11.6.1 Quest Diagnostics Corporation Information

11.6.2 Quest Diagnostics Overview

11.6.3 Quest Diagnostics COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Quest Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Quest Diagnostics Recent Developments

11.7 Abbott

11.7.1 Abbott Corporation Information

11.7.2 Abbott Overview

11.7.3 Abbott COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Abbott COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Abbott Recent Developments

11.8 Quidel

11.8.1 Quidel Corporation Information

11.8.2 Quidel Overview

11.8.3 Quidel COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Quidel COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Quidel Recent Developments

11.9 BioFire Diagnostics

11.9.1 BioFire Diagnostics Corporation Information

11.9.2 BioFire Diagnostics Overview

11.9.3 BioFire Diagnostics COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 BioFire Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 BioFire Diagnostics Recent Developments

11.10 BGI Genomics

11.10.1 BGI Genomics Corporation Information

11.10.2 BGI Genomics Overview

11.10.3 BGI Genomics COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 BGI Genomics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 BGI Genomics Recent Developments

11.11 BioMedomics

11.11.1 BioMedomics Corporation Information

11.11.2 BioMedomics Overview

11.11.3 BioMedomics COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 BioMedomics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 BioMedomics Recent Developments

11.12 Cepheid

11.12.1 Cepheid Corporation Information

11.12.2 Cepheid Overview

11.12.3 Cepheid COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Cepheid COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Cepheid Recent Developments

11.13 Chembio Diagnostics

11.13.1 Chembio Diagnostics Corporation Information

11.13.2 Chembio Diagnostics Overview

11.13.3 Chembio Diagnostics COVID-19 Antigen Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Chembio Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Chembio Diagnostics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 COVID-19 Antigen Kit Industry Chain Analysis

12.2 COVID-19 Antigen Kit Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 COVID-19 Antigen Kit Production Mode & Process

12.4 COVID-19 Antigen Kit Sales and Marketing

12.4.1 COVID-19 Antigen Kit Sales Channels

12.4.2 COVID-19 Antigen Kit Distributors

12.5 COVID-19 Antigen Kit Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 COVID-19 Antigen Kit Industry Trends

13.2 COVID-19 Antigen Kit Market Drivers

13.3 COVID-19 Antigen Kit Market Challenges

13.4 COVID-19 Antigen Kit Market Restraints

14 Key Findings in The Global COVID-19 Antigen Kit Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

Table 1. Global COVID-19 Antigen Kit Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Rapid Detection Kit

Table 3. Major Manufacturers of PCR Kit

Table 4. Global COVID-19 Antigen Kit Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global COVID-19 Antigen Kit Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global COVID-19 Antigen Kit Sales by Region (2017-2022) & (K Units)

Table 7. Global COVID-19 Antigen Kit Sales Market Share by Region (2017-2022)

Table 8. Global COVID-19 Antigen Kit Sales by Region (2023-2028) & (K Units)

Table 9. Global COVID-19 Antigen Kit Sales Market Share by Region (2023-2028)

Table 10. Global COVID-19 Antigen Kit Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global COVID-19 Antigen Kit Revenue Market Share by Region (2017-2022)

Table 12. Global COVID-19 Antigen Kit Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global COVID-19 Antigen Kit Revenue Market Share by Region (2023-2028)

Table 14. Global COVID-19 Antigen Kit Sales by Manufacturers (2017-2022) & (K Units)

Table 15. Global COVID-19 Antigen Kit Sales Share by Manufacturers (2017-2022)

Table 16. Global COVID-19 Antigen Kit Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global COVID-19 Antigen Kit Revenue Share by Manufacturers (2017-2022)

Table 18. COVID-19 Antigen Kit Price by Manufacturers (2017-2022) &(US$/Unit)

Table 19. Global COVID-19 Antigen Kit Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global COVID-19 Antigen Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Antigen Kit as of 2021)

Table 21. COVID-19 Antigen Kit Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers COVID-19 Antigen Kit Product Offered

Table 23. Date of Manufacturers Enter into COVID-19 Antigen Kit Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 26. Global COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 27. Global COVID-19 Antigen Kit Sales Share by Type (2017-2022)

Table 28. Global COVID-19 Antigen Kit Sales Share by Type (2023-2028)

Table 29. Global COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global COVID-19 Antigen Kit Revenue Share by Type (2017-2022)

Table 32. Global COVID-19 Antigen Kit Revenue Share by Type (2023-2028)

Table 33. COVID-19 Antigen Kit Price by Type (2017-2022) & (US$/Unit)

Table 34. Global COVID-19 Antigen Kit Price Forecast by Type (2023-2028) & (US$/Unit)

Table 35. Global COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 36. Global COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 37. Global COVID-19 Antigen Kit Sales Share by Application (2017-2022)

Table 38. Global COVID-19 Antigen Kit Sales Share by Application (2023-2028)

Table 39. Global COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global COVID-19 Antigen Kit Revenue Share by Application (2017-2022)

Table 42. Global COVID-19 Antigen Kit Revenue Share by Application (2023-2028)

Table 43. COVID-19 Antigen Kit Price by Application (2017-2022) & (US$/Unit)

Table 44. Global COVID-19 Antigen Kit Price Forecast by Application (2023-2028) & (US$/Unit)

Table 45. North America COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 46. North America COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 47. North America COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 50. North America COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 51. North America COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America COVID-19 Antigen Kit Sales by Country (2017-2022) & (K Units)

Table 54. North America COVID-19 Antigen Kit Sales by Country (2023-2028) & (K Units)

Table 55. North America COVID-19 Antigen Kit Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America COVID-19 Antigen Kit Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 58. Europe COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 59. Europe COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 62. Europe COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 63. Europe COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe COVID-19 Antigen Kit Sales by Country (2017-2022) & (K Units)

Table 66. Europe COVID-19 Antigen Kit Sales by Country (2023-2028) & (K Units)

Table 67. Europe COVID-19 Antigen Kit Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe COVID-19 Antigen Kit Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 70. Asia Pacific COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 71. Asia Pacific COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 74. Asia Pacific COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 75. Asia Pacific COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific COVID-19 Antigen Kit Sales by Region (2017-2022) & (K Units)

Table 78. Asia Pacific COVID-19 Antigen Kit Sales by Region (2023-2028) & (K Units)

Table 79. Asia Pacific COVID-19 Antigen Kit Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific COVID-19 Antigen Kit Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 82. Latin America COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 83. Latin America COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 86. Latin America COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 87. Latin America COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America COVID-19 Antigen Kit Sales by Country (2017-2022) & (K Units)

Table 90. Latin America COVID-19 Antigen Kit Sales by Country (2023-2028) & (K Units)

Table 91. Latin America COVID-19 Antigen Kit Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America COVID-19 Antigen Kit Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa COVID-19 Antigen Kit Sales by Type (2017-2022) & (K Units)

Table 94. Middle East and Africa COVID-19 Antigen Kit Sales by Type (2023-2028) & (K Units)

Table 95. Middle East and Africa COVID-19 Antigen Kit Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa COVID-19 Antigen Kit Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa COVID-19 Antigen Kit Sales by Application (2017-2022) & (K Units)

Table 98. Middle East and Africa COVID-19 Antigen Kit Sales by Application (2023-2028) & (K Units)

Table 99. Middle East and Africa COVID-19 Antigen Kit Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa COVID-19 Antigen Kit Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa COVID-19 Antigen Kit Sales by Country (2017-2022) & (K Units)

Table 102. Middle East and Africa COVID-19 Antigen Kit Sales by Country (2023-2028) & (K Units)

Table 103. Middle East and Africa COVID-19 Antigen Kit Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa COVID-19 Antigen Kit Revenue by Country (2023-2028) & (US$ Million)

Table 105. Assay Genie Corporation Information

Table 106. Assay Genie Description and Major Businesses

Table 107. Assay Genie COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 108. Assay Genie COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Assay Genie Recent Developments

Table 110. Arista Biotech Corporation Information

Table 111. Arista Biotech Description and Major Businesses

Table 112. Arista Biotech COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 113. Arista Biotech COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Arista Biotech Recent Developments

Table 115. Becton Corporation Information

Table 116. Becton Description and Major Businesses

Table 117. Becton COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 118. Becton COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Becton Recent Developments

Table 120. Ellume Corporation Information

Table 121. Ellume Description and Major Businesses

Table 122. Ellume COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 123. Ellume COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Ellume Recent Developments

Table 125. iHealth Lab Corporation Information

Table 126. iHealth Lab Description and Major Businesses

Table 127. iHealth Lab COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 128. iHealth Lab COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. iHealth Lab Recent Developments

Table 130. Quest Diagnostics Corporation Information

Table 131. Quest Diagnostics Description and Major Businesses

Table 132. Quest Diagnostics COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 133. Quest Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Quest Diagnostics Recent Developments

Table 135. Abbott Corporation Information

Table 136. Abbott Description and Major Businesses

Table 137. Abbott COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 138. Abbott COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Abbott Recent Developments

Table 140. Quidel Corporation Information

Table 141. Quidel Description and Major Businesses

Table 142. Quidel COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 143. Quidel COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Quidel Recent Developments

Table 145. BioFire Diagnostics Corporation Information

Table 146. BioFire Diagnostics Description and Major Businesses

Table 147. BioFire Diagnostics COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 148. BioFire Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. BioFire Diagnostics Recent Developments

Table 150. BGI Genomics Corporation Information

Table 151. BGI Genomics Description and Major Businesses

Table 152. BGI Genomics COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 153. BGI Genomics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. BGI Genomics Recent Developments

Table 155. BioMedomics Corporation Information

Table 156. BioMedomics Description and Major Businesses

Table 157. BioMedomics COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 158. BioMedomics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. BioMedomics Recent Developments

Table 160. Cepheid Corporation Information

Table 161. Cepheid Description and Major Businesses

Table 162. Cepheid COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 163. Cepheid COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Cepheid Recent Developments

Table 165. Chembio Diagnostics Corporation Information

Table 166. Chembio Diagnostics Description and Major Businesses

Table 167. Chembio Diagnostics COVID-19 Antigen Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 168. Chembio Diagnostics COVID-19 Antigen Kit Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Chembio Diagnostics Recent Developments

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. COVID-19 Antigen Kit Distributors List

Table 173. COVID-19 Antigen Kit Customers List

Table 174. COVID-19 Antigen Kit Market Trends

Table 175. COVID-19 Antigen Kit Market Drivers

Table 176. COVID-19 Antigen Kit Market Challenges

Table 177. COVID-19 Antigen Kit Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. COVID-19 Antigen Kit Product Picture

Figure 3. Global COVID-19 Antigen Kit Market Share by Type in 2021 & 2028

Figure 3. Rapid Detection Kit Product Picture

Figure 4. PCR Kit Product Picture

Figure 5. Global COVID-19 Antigen Kit Market Share by Application in 2021 & 2028

Figure 6. Domestic Use

Figure 7. Clinic

Figure 8. Hospital

Figure 9. Others

Figure 10. COVID-19 Antigen Kit Report Years Considered

Figure 11. Global COVID-19 Antigen Kit Sales 2017-2028 (K Units)

Figure 12. Global COVID-19 Antigen Kit Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global COVID-19 Antigen Kit Revenue 2017-2028 (US$ Million)

Figure 14. Global COVID-19 Antigen Kit Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global COVID-19 Antigen Kit Sales Market Share by Region (2017-2022)

Figure 16. Global COVID-19 Antigen Kit Sales Market Share by Region (2023-2028)

Figure 17. North America COVID-19 Antigen Kit Sales YoY (2017-2028) & (K Units)

Figure 18. North America COVID-19 Antigen Kit Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe COVID-19 Antigen Kit Sales YoY (2017-2028) & (K Units)

Figure 20. Europe COVID-19 Antigen Kit Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific COVID-19 Antigen Kit Sales YoY (2017-2028) & (K Units)

Figure 22. Asia-Pacific COVID-19 Antigen Kit Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America COVID-19 Antigen Kit Sales YoY (2017-2028) & (K Units)

Figure 24. Latin America COVID-19 Antigen Kit Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa COVID-19 Antigen Kit Sales YoY (2017-2028) & (K Units)

Figure 26. Middle East & Africa COVID-19 Antigen Kit Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The COVID-19 Antigen Kit Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of COVID-19 Antigen Kit in the World: Market Share by COVID-19 Antigen Kit Revenue in 2021

Figure 29. Global COVID-19 Antigen Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 31. Global COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 32. Global COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 33. Global COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 34. North America COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 35. North America COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 36. North America COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 37. North America COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 38. North America COVID-19 Antigen Kit Sales Share by Country (2017-2028)

Figure 39. North America COVID-19 Antigen Kit Revenue Share by Country (2017-2028)

Figure 40. United States COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 41. Canada COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 42. Europe COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 43. Europe COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 44. Europe COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 45. Europe COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 46. Europe COVID-19 Antigen Kit Sales Share by Country (2017-2028)

Figure 47. Europe COVID-19 Antigen Kit Revenue Share by Country (2017-2028)

Figure 48. Germany COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 49. France COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 51. Italy COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 52. Russia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific COVID-19 Antigen Kit Sales Share by Region (2017-2028)

Figure 58. Asia Pacific COVID-19 Antigen Kit Revenue Share by Region (2017-2028)

Figure 59. China COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 60. Japan COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 62. India COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 63. Australia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 64. China Taiwan COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 69. Latin America COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 70. Latin America COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 71. Latin America COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 72. Latin America COVID-19 Antigen Kit Sales Share by Country (2017-2028)

Figure 73. Latin America COVID-19 Antigen Kit Revenue Share by Country (2017-2028)

Figure 74. Mexico COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 77. Colombia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa COVID-19 Antigen Kit Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa COVID-19 Antigen Kit Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa COVID-19 Antigen Kit Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa COVID-19 Antigen Kit Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa COVID-19 Antigen Kit Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa COVID-19 Antigen Kit Revenue Share by Country (2017-2028)

Figure 84. Turkey COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 86. UAE COVID-19 Antigen Kit Revenue (2017-2028) & (US$ Million)

Figure 87. COVID-19 Antigen Kit Value Chain

Figure 88. COVID-19 Antigen Kit Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新型コロナウイルス感染症 抗原キットの世界市場インサイト・予測(~2028年)(Global COVID-19 Antigen Kit Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆